Advanced Medicine Recall is written primarily for fourth year medical students, sub-interns, and interns. It expands upon the core clinical specialty areas within internal medicine—cardiology, pulmonology, nephrology, gastroenterology, hematology, oncology, infectious disease, endocrinology, allergy and immunology, rheumatology, neurology, and dermatology. This book is written in the rapid-fire question and answer format of the Recall Series, with the question on the left side of the page and the answer on the right. Mnemonics are interspersed throughout. Additional chapters in Advanced Medicine Recall include Environmental Medicine, Psychiatry, and The Consultant. The focus of the advanced material is on differential diagnosis, patient management, and disease management.
Written primarily for third- and fourth-year medical students in clerkships, this new edition covers the core specialty areas within internal medicine, including cardiology, pulmonology, and oncology. Each chapter is written by faculty, students, and fellows and emphasizes diagnosis and treatment.
Now in its Sixth Edition, Surgical Recall allows for rapid-fire review of surgical clerkship material for third- or fourth-year medical students preparing for the USMLE and shelf exams. Written in a concise question-and-answer format—double-column, question on the left, answer on the right—Surgical Recall addresses both general surgery and surgical subspecialties. Students on rotation or being PIMPed can quickly refer to Surgical Recall for accurate and on-the-spot answers. The book includes survival tactics and tips for success on the boards and wards as well as key information for those new to the surgical suite.
Advanced Surgical Recall, Third Edition is a quick review for the ABSITE and oral board exams in surgery. The book is written in rapid-fire question-and-answer format and contains detailed illustrations of anatomic landmarks and surgical techniques. This edition has seven new Microvignettes chapters that test recall via sample cases. These Microvignettes chapters include Clinical, Surgical Pathognomonic, Complications, Blood, Surgical Laboratory, Medical Treatment of Surgical Diagnoses, and Eponyms. Other new chapters include Advanced Procedures, Cell Biology and Cytokines, Wounds, Drains and Tubes, Surgical Respiratory Care, Renal Facts, Surgery by the Numbers and Surgical Formulae, Hand Surgery, Obstetrics and Gynecology, Diagnostic Surgical Stimulation and Radiographic Tests, and Power Review of Surgical Physiology.
Following its acclaimed predecessor Pediatrics Recall, this new Second Edition reviews disease entities to facilitate retention and mimic verbal testing covered in a pediatric clerkship. Its unique question-and-answer format is retained. This edition is organized by disease process and involved systems. The text includes descriptions, signs, symptoms, pathophysiology essentials, treatments and possible outcomes. New to this edition are some select figures. Topics cover basic issues in neonatal and pediatric fluid management, blood products, nutrition, growth, emergencies, and intensive care. One chapter is solely devoted to issues relating to the adolescent patient. Easy access design is ideal for clinical rotation usage.
Getting the right diagnosis is a key aspect of health care - it provides an explanation of a patient's health problem and informs subsequent health care decisions. The diagnostic process is a complex, collaborative activity that involves clinical reasoning and information gathering to determine a patient's health problem. According to Improving Diagnosis in Health Care, diagnostic errors-inaccurate or delayed diagnoses-persist throughout all settings of care and continue to harm an unacceptable number of patients. It is likely that most people will experience at least one diagnostic error in their lifetime, sometimes with devastating consequences. Diagnostic errors may cause harm to patients by preventing or delaying appropriate treatment, providing unnecessary or harmful treatment, or resulting in psychological or financial repercussions. The committee concluded that improving the diagnostic process is not only possible, but also represents a moral, professional, and public health imperative. Improving Diagnosis in Health Care, a continuation of the landmark Institute of Medicine reports To Err Is Human (2000) and Crossing the Quality Chasm (2001), finds that diagnosis-and, in particular, the occurrence of diagnostic errorsâ€"has been largely unappreciated in efforts to improve the quality and safety of health care. Without a dedicated focus on improving diagnosis, diagnostic errors will likely worsen as the delivery of health care and the diagnostic process continue to increase in complexity. Just as the diagnostic process is a collaborative activity, improving diagnosis will require collaboration and a widespread commitment to change among health care professionals, health care organizations, patients and their families, researchers, and policy makers. The recommendations of Improving Diagnosis in Health Care contribute to the growing momentum for change in this crucial area of health care quality and safety.
Globalization is rapidly changing lives and industries around the world. Drug development, authorization, and regulatory supervision have become international endeavors, with most medicines becoming global commodities. Drug companies utilize global supply chains that often include facilities in countries with inconsistent regulations from those of the United States, perform pivotal trials in multiple countries to support registration submissions in various jurisdictions, and subsequently market their medicines throughout most of the world. These companies operate across borders and require individual national regulators to ensure that drugs authorized for use in their countries are safe and effective, and appropriate for their health care system and their population. This process involves significant resources and often duplicative work. It is important to consider how this process can be improved in order to better allocate resources, time, and efforts to improve public health. Regulating Medicines in a Globalized World: The Need for Increased Reliance Among Regulators considers the role of mutual recognition and other reliance activities among regulators in contributing to enhancing public health. This report identifies opportunities for leveraging reliance activities more broadly in order to potentially impact public health globally. Key topics in this report include the job of medicines regulators in today's world, what policy makers need to know about today's regulatory environment, stakeholder views of recognition and reliance, as well as removing impediments and facilitating action for greater recognition and reliance among regulatory authorities.
Written by experts in the field, students, and residents, Radiology Recall facilitates rapid learning and memorization with a concise question and answer format.
During the early years of the AIDS epidemic, thousands of Americans became infected with HIV through the nation's blood supply. Because little reliable information existed at the time AIDS first began showing up in hemophiliacs and in others who had received transfusions, experts disagreed about whether blood and blood products could transmit the disease. During this period of great uncertainty, decision-making regarding the blood supply became increasingly difficult and fraught with risk. This volume provides a balanced inquiry into the blood safety controversy, which involves private sexual practices, personal tragedy for the victims of HIV/AIDS, and public confidence in America's blood services system. The book focuses on critical decisions as information about the danger to the blood supply emerged. The committee draws conclusions about what was doneâ€"and recommends what should be done to produce better outcomes in the face of future threats to blood safety. The committee frames its analysis around four critical area: Product treatmentâ€"Could effective methods for inactivating HIV in blood have been introduced sooner? Donor screening and referralâ€"including a review of screening to exlude high-risk individuals. Regulations and recall of contaminated bloodâ€"analyzing decisions by federal agencies and the private sector. Risk communicationâ€"examining whether infections could have been averted by better communication of the risks.
